These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30173640)

  • 1. Review of evidence on handling hazardous drugs and Products in Urology Services; consensus document between the Spanish Urology Association and the Spanish Society of Health-System Pharmacists.
    Unda-Urzáiz M; Alonso-Herreros JM; Fernández-Gómez JM; Gaspar-Carreño M; Cozar-Olmos JM; Cercós Lleti AC
    Farm Hosp; 2018 Sep; 42(5):212-215. PubMed ID: 30173640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the evidence on handling drugs and hazardous products in Urology Departments. Consensus document between the Spanish Urological Association and the Spanish Society of Hospital Pharmacy.
    Unda-Urzaiz M; Alonso-Herreros JM; Fernandez-Gomez JM; Gaspar-Carreño M; Cozar-Olmos JM; Lleti ACC;
    Actas Urol Esp (Engl Ed); 2018; 42(6):375-380. PubMed ID: 29685610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).
    Valero-García S; González-Haba E; Gorgas-Torner MQ; Alonso-Herreros JM; Cercós Lletí AC; Poveda-Andrés JL; Calleja-Hernandez MÁ; Delgado-Sánchez O
    Farm Hosp; 2021 Mar; 45(2):96-107. PubMed ID: 33709894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus to identify the dangerous drugs risks in hospital pharmacy services.
    Bernabeu-Martínez MÁ; García-Salom P; Burgos-San José A; Navarro-Ruiz A; Sanz-Valero J; Wanden-Berghe C
    Farm Hosp; 2020 Mar; 44(2):51-61. PubMed ID: 32452316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the new handling recommendations for hazardous drugs in a hospital pharmacy service.
    García-Alcántara BG; Perelló Alomar C; Moreno Centeno E; Modamio P; Mariño EL; Delgado Sánchez O
    Farm Hosp; 2017 Mar; 41(2):257-269. PubMed ID: 28236800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on safe handling of hazardous drugs: the advice of experts.
    Power LA; Anderson RW; Cortopassi R; Gera JR; Lewis RM
    Am J Hosp Pharm; 1990 May; 47(5):1050-60. PubMed ID: 2186622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hazardous drugs: new challenges, new opportunities.
    Valero García S; López Briz E; Vila Clérigues N; Poveda Andrés JL
    Farm Hosp; 2016 Mar; 40(2):124-7. PubMed ID: 26980170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safe procedure development to manage hazardous drugs in the workplace.
    Gaspar Carreño M; Achau Muñoz R; Torrico Martín F; Agún Gonzalez JJ; Sanchez Santos JC; Cercos Lletí AC; Ramos Orozco P
    Farm Hosp; 2017 Mar; 41(2):222-256. PubMed ID: 28236799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to Precautionary Guidelines for Compounding Antineoplastic Drugs: A Survey of Nurses and Pharmacy Practitioners.
    Boiano JM; Steege AL; Sweeney MH
    J Occup Environ Hyg; 2015; 12(9):588-602. PubMed ID: 25897702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USP <800>: Gaining Compliance Through Implementation of a Hazardous Drug Control Program.
    Blake K
    Clin J Oncol Nurs; 2019 Jun; 23(3):324-326. PubMed ID: 31099798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive program for handling hazardous drugs.
    Arrington DM; McDiarmid MA
    Am J Hosp Pharm; 1993 Jun; 50(6):1170-4. PubMed ID: 8517456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive tackling to the safe handling of hazardous drugs: a multidisciplinary approach to clinical practice.
    Vuelta-Arce M; Chiapella-Micó C; Mestre-Prad MT; Teixidó-Huerta X; Del Estal-Jiménez J; Rodríguez-Gías E; Guinovart-Alemany M
    Int J Occup Med Environ Health; 2020 Sep; 33(5):621-634. PubMed ID: 32716012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of guidelines and current practices for safe handling of antineoplastic and other hazardous drugs used in 24 countries.
    Mathias PI; MacKenzie BA; Toennis CA; Connor TH
    J Oncol Pharm Pract; 2019 Jan; 25(1):148-162. PubMed ID: 28841099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hazardous drugs.
    Black LA; Presson AC
    Occup Med; 1997; 12(4):669-85. PubMed ID: 9353816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the safe handling of hazardous drugs: consensus recommendations.
    Chaffee BW; Armitstead JA; Benjamin BE; Cotugno MC; Forrey RA; Hintzen BL; Pfeiffenberger T; Stevenson JG
    Am J Health Syst Pharm; 2010 Sep; 67(18):1545-6. PubMed ID: 20811033
    [No Abstract]   [Full Text] [Related]  

  • 16. Consensus SEO-SEFH of recommendations for use and compounding of ophthalmic preparations.
    Fuentes-Irigoyen R; Martín de Rosales Cabrera AM; Riestra AC; Vila MN; Dávila-Pousa C; Alonso Herreros JM; López-Cabezas C; Cañete C; Pernía-López MS; Garcia-Palomo M; Arriola Villalobos P; Ibares-Frías L; Urcelay Segura JL; Yañez Martínez JR
    Farm Hosp; 2018 Mar; 42(2):82-88. PubMed ID: 29501060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study.
    Valero-García S; Poveda-Andrés JL
    Farm Hosp; 2018 Jul; 42(4):152-158. PubMed ID: 29959839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A practical approach to assess the hazardous exposure potential of investigational drugs.
    McLeod EN; Fillis CJ; Blind JE
    Am J Health Syst Pharm; 2020 Apr; 77(9):697-700. PubMed ID: 34278414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complying with workers' right-to-know legislation.
    Knoeck MJ; Wadd WB; Giese RM
    Am J Hosp Pharm; 1985 Sep; 42(9):1974-6. PubMed ID: 4050815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of a novel product to remove surface contamination of hazardous drugs.
    Cox J; Speed V; O'Neal S; Hasselwander T; Sherwood C; Eckel SF; Zamboni WC
    J Oncol Pharm Pract; 2017 Mar; 23(2):103-115. PubMed ID: 26673538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.